Panniculitis market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 5.60% in the above mentioned forecast period.
Panniculitis is the inflammation of the fat layer present under the skin. This condition causes the formation of painful nodes under the skin, often on legs and feet. These formed nodules are the reason for the inflammation of fat layer under skin. These nodules are painful and sometimes also appear on the face, arms, chest and abdomen. The symptoms of this condition are fatigue, abdominal pain, fever, muscle pain, malaise, weight loss, bulging of eyes, nausea and vomiting.
Rise in the prevalence of bacterial infections, inflammatory disease, alpha-1 antitrypsin deficiency, connective tissue disorders, sarcoidosis and pancreatic diseases as these conditions causes panniculitis and will act as a major driver for the market growth. Furthermore, growing healthcare expenditure, development of treatment options, growing government funding, rising initiatives by government and private organisations to spread awareness about the disease and its treatment are the factors that will expand the panniculitis market.
Rise in the research and development activities and emerging markets will provide beneficial opportunities for the panniculitis market in the forecast period of 2021-2028.
Read Full Report Summary @ https://www.databridgemarketresearch.com/reports/global-panniculitis-market
North America dominates the panniculitis market due to the presence of major key players, growing investment for RD activities, high healthcare expenditure and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.
The major players covered in the panniculitis market report are Allergan, Merck Sharp Dohme Corp., Pfizer Inc., GlaxoSmithKline plc, Paratek Pharmaceuticals, Inc., Abbott, F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Bayer AG, Sun Pharmaceutical Industries Ltd., Lilly, Aurobindo Pharma, Lupin, AbbVie Inc., AstraZeneca, Johnson Johnson Private Limited, Sumitomo Corporation, Merck KGaA, LEO Pharma A/S, Cipla Inc., Bristol-Myers Squibb Company, and Astellas Pharma Inc., among other domestic and global players.
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
